×
Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia PDF
$ 40.00
Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia PDF quantity
$ 40.00
×
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial PDF
$ 40.00
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial PDF quantity
$ 40.00
×
Prevalence of Hyperprolactinemia in Schizophrenia: Association With Typical and Atypical Antipsychotic Treatment PDF
$ 40.00
Prevalence of Hyperprolactinemia in Schizophrenia: Association With Typical and Atypical Antipsychotic Treatment PDF quantity
$ 40.00
×
The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long-Term Treatment PDF
$ 40.00
The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long-Term Treatment PDF quantity
$ 40.00
×
Capacity Assessment and Involuntary Commitment in Psychiatric and Medical Settings: Clinical, Legal, and Cultural Considerations PDF
$ 40.00
Capacity Assessment and Involuntary Commitment in Psychiatric and Medical Settings: Clinical, Legal, and Cultural Considerations PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart